title: Neuropeptide Levels as well as Neprilysin Activity Decrease in Renal Cell Carcinoma.
abstract: Calcitonin Gene-related Peptide (CGRP), Vasoactive Intestinal Peptide (VIP) and Substance P (SP) are sensory neuropeptides which may alter cancer growth through modulation of chronic inflammation. We recently reported that SP suppresses breast cancer growth and metastasis through neuroimmune modulation. These neuropeptides are hydrolyzed by Neprilysin (NEP) to bioactive fragments. Decreased activity of NEP was reported in clear cell and chromophobe type renal cell carcinoma (RCC). It is however not known how the levels of neuropeptides hydrolyzed with NEP changes in RCC. Decrease activity of SP and CGRP containing sensory nerve endings was previously reported to increase cancer metastasis in animal models. It is however not known how peptidergic nerve endings are altered in RCC. Hence we here evaluated the levels of neuronal and non-neuronal neuropeptides and NEP activity in RCC including papillary type as well as neighboring uninvolved kidney. A cross-sectional study was conducted in 57 patients undergoing radical nephrectomy and diagnosed with RCC. NEP activity, levels and expression were determined using flourogenic substrate, western blot and qPCR respectively in freshly-frozen tissues. Immunohistochemical analyses were also performed. Neuronal and non-neuronal levels of CGRP, SP and VIP levels were determined using two-step acetic acid extraction. Levels and activity of NEP were markedly decreased in RCC regardless of subtype. Similar levels of VIP were detected in first and second extractions. VIP levels were higher in clear cell and papillary RCC compared to nearby kidney tissue. VIP levels of neighboring kidney tissue of papillary type RCC was significantly lower compared to kidney samples from clear cell RCC. CGRP levels were higher in second extraction. Similar to VIP levels, CGRP levels of neighboring kidney tissue from clear cell and chromophobe type RCC was significantly lower compared to corresponding tumor samples, an effect observed in the second extraction. VIP and CGRP levels of nearby kidney tissue varied subtype dependently demonstrating that different subtypes of RCC alter their local environment differently. Furthermore NEP-induce hydrolysis of VIP creates selective VPAC-1 receptor agonist which has anti-proliferative and anti-inflammatory effects. Hence loss of NEP activity may prevent anti-tumoral effects of VIP on RCC.
authors.affiliation: Department of Medical Pharmacology, School of Medicine, Akdeniz University, Antalya, Turkey. nerin@akdeniz.edu.tr.
authors.forename: Nuray
authors.initials: N
authors.lastname: Erin
authors.affiliation: School of Medicine, Urology and Pathology Akdeniz University, Antalya, Turkey.
authors.forename: Tümay
authors.initials: T
authors.lastname: İpekçi
authors.affiliation: Department of Pathology, School of Medicine, Akdeniz University, Antalya, Turkey.
authors.forename: Bahar
authors.initials: B
authors.lastname: Akkaya
authors.affiliation: Department of Pathology, School of Medicine, Akdeniz University, Antalya, Turkey.
authors.forename: İrem Hicran
authors.initials: İH
authors.lastname: Özbudak
authors.affiliation: Department of Urology, School of Medicine, Akdeniz University, Antalya, Turkey.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Baykara
keywords: CGRP; Neutral endopeptidase; Renal cell carcinoma; VIP